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Abstract: Preschool wheezing and related hospitalization rates are increasing. Prenatal tobacco
smoke exposure (PTSE) increases the risk of wheezing, yet >20% of French women smoke during
pregnancy. In this observational retrospective monocentric study, we assessed the link between PTSE
and hospital admissions. We included infants <2 years of age admitted for acute wheezing. A phone
interview with mothers was completed by electronic records. The primary endpoint was the ratio of
cumulative duration of the hospitalization stays (days)/age (months). 129 children were included
(36.4% exposed to PTSE vs. 63.6% unexposed). There was a significant difference in the duration
of hospitalization/age: 0.9 days/month (exposed) vs. 0.58 days/month (unexposed) (p = 0.008).
Smoking one cigarette/day during pregnancy was associated with an increase in hospitalization
duration of 0.055 days/month (r = 0.238, p = 0.006). In the multi-variable analysis, this positive
association persisted (β = 0.04, p = 0.04; standardized β = 0.27, p = 0.03). There was a trend towards
a dose-effect relationship between PTSE and other important parameters associated with hospital
admissions. We have demonstrated a dose-effect relationship, without a threshold effect, between
PTSE and duration of hospitalization for wheezing in non-premature infants during the first 2 years
of life. Prevention campaigns for future mothers should be enforced.
Keywords: asthma; child; preschool; prenatal exposure; delayed effects; pregnancy; smoking;
adverse effect
1. Introduction
It is estimated that 15–37% of women smoke while pregnant [1]. In 2017 in France
smoking during pregnancy was estimated to affect between 20% and 25% of pregnant
women, and was more frequent amongst the youngest and least educated women [2].
There is a wide range of effects of prenatal tobacco smoke exposure (PTSE) on mortality
and morbidity in infants and children. Maternal smoking increases the risk of obstetric
complications, preterm birth, low birth weight and poor intrauterine growth, infant death
(Sudden Infant Death Syndrome), neurodevelopmental and behavioral problems and
possibly childhood cancer [1,3]. Regarding the lung, it is generally accepted that there
is reduced and disturbed intra-uterine lung growth and as a consequence an increased
incidence of acute lower airway infections (0–3 years), persisting reduced lung function
and increased incidence of wheeze (0–5 years) [1,3,4].
Preschool wheeze is a multifactorial disease whose expression depends on the envi-
ronment. Its prevalence and related hospitalization rate are increasing [5,6]. The influence
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of PTSE on the development of preschool wheeze is known to cause at least a 20% increase
in wheezing and asthma rates. The wheezing phenotype most closely associated with PTSE
is transient early wheezing, i.e., at least one lower respiratory tract illness with wheezing
during the first three years of life but no wheezing at six years of age. This is accompanied
by significantly lower length-adjusted values for Vsub maxFRC in infancy [7].
Most studies describe a pathophysiological and clinical dose-effect relationship, but
with varying thresholds [5,6]. Moreover, the clinical impact in mothers and infants regard-
ing hospitalizations during the first 1000 days is not well known. In the present study,
we thus analyzed the dose-effect relationship between PTSE and the duration of hospi-
talization for wheezing in infants under 2 years of age in a French tertiary-care regional
reference center, i.e., the Bordeaux Children’s University Hospital. We also analyzed the
dose-effect relationship between this exposure and the severity of dyspnea during hospital
admissions, how mothers experienced their child’s hospitalizations and the associated rate
of parental workplace absenteeism, the number of consultations in pediatric emergency
departments’ services for wheezing and the age of the first episode of wheezing.
2. Methods
This was a retrospective single-center observational study conducted from July 2016
to February 2017. The Ethics Committee and Institutional Review Board of Bordeaux
University Hospital validated this project and waived the necessity of written informed
consent. The mothers called were informed about the objective of the study and agreed
to answer the questionnaire. Data use met the requirements of the CNIL, which is the
French data protection authority, and all data were anonymized. Patients included had
been hospitalized at least once for an episode of wheezy dyspnea, from January 2015 to
May 2016 at Bordeaux Children’s Hospital. They were less than 2 years old at the time
of hospitalization. Patients had had at least three episodes of wheezy dyspnea in their
lifetime, or at least two episodes with a family or personal history of atopy. Patients who
were born preterm (<37 weeks of gestation) and who had comorbidities such as heart
disease, immune deficiency, degenerative neuromuscular pathology, upper and lower
airway malformations, or severe laryngo-tracheomalacia were excluded.
The data was collected from the patients’ files (Dx Care® software, Medasys, Paris,
France) and completed by a maternal questionnaire. For the latter, we conducted a tele-
phone questionnaire interview with the mothers of hospitalized infants. We collected
patient characteristics, the existence of family or personal atopy, the main risk factors
for preschool wheezing, API (Asthma Predictive Index) [8] and PIAMA (Prevention and
Incidence of Asthma and Mite Allergy) [9] scores to phenotype asthma, and socio-economic
level as assessed by educational level (if more or less than grade 12). We also collected
data regarding hospitalization and medical respiratory history. The severity of dyspnea
during hospitalization was defined by oxygen requirement, and/or complications such as
pneumonia or atelectasis. Mothers graded from 0 (very bad experience) to 5 (good) their
experience of their child’s hospitalizations. We documented the rate of parental workplace
absenteeism and the number of emergency visits for wheezing, as well as PTSE as de-
scribed by the mothers. The other types of passive smoking were also noted, i.e., as passive
smoking for pregnant women, partner smoking and post-natal passive smoking. We noted
the mothers’ behaviors related to smoking cessation or reduction and the information given
to mothers regarding the risk of asthma for the child if exposed to prenatal tobacco smoke.
The primary endpoint was the duration in days of hospitalization for wheezy dyspnea
related to the patient’s age in months, i.e., the ratio “duration of hospitalization/age”. If
the patient had been hospitalized several times, the duration of hospitalization was the
cumulative duration of all stays normalized to the age at the last hospital admission.
Statistical analysis was performed using several types of software: Excel 2010, Mi-
crosoft Redmond, USA; NCSS 2001, Kaysville, Utah, USA and Sas 9.4, SAS Institute Inc.,
Cary, NC, USA. Data were expressed as means ± SD or as median (IQR). Quantitative and
qualitative values were compared using Mann-Whitney and Fisher tests. A linear multi-
Healthcare 2021, 9, 1089 3 of 11
variable regression was performed with Sas 9.4 using Proc reg. Standardized coefficients
were calculated, and the same procedure applied.
3. Results
A total of 237 patients were recruited. Of the 129 responses obtained by the telephone
questionnaire interview, 47/129 (36.4%) infants had been exposed to prenatal tobacco
smoking and 82/129 (63.6%) infants had not. The general characteristics of the study
population are summarized in Table 1.









N 129 82 47
Sex
F 37 (29) 29 (35) 8 (17) 0.03
M 92 (71) 53 (65) 39 (83)
Birth weight (kg) 3.25 ± 0.43 3.35 ± 0.42 3.09 ± 0.39 0.007
IUGR 11 (9) 6 (7) 5 (11) 0.53
Familial atopy 68 (53) 44 (54) 24 (51) 0.85
Low social level 50 (39) 23 (28) 27 (57) 0.001
Personal atopy 59 (46) 38 (46) 21 (45) 1
Positive API 91 (71) 57 (70) 34 (72) 0.84




9.9 ± 6.38 10.9 ± 6.5 8.4 ± 5.9 0.03
Number of
hospitalisations
1 67 (52) 44 (54) 23 (49)
>1 62 (48) 38 (46) 24 (51)
n (%); Mean ± SD. API: Asthma Predictive Index; IUGR: Intra-Uterine Growth Retardation; PIAMA: Prevention
and Incidence of Asthma and Mite allergy; PTSE: Prenatal Tobacco Smoke Exposure. Bold numbers indicate
significant differences between the PTSE exposed vs. non-exposed patients
Compared to the population of patients with wheezing/asthma admitted during the
same time frame, included patients were younger upon their first wheezing episodes and
had more severe disease. However, the sex ratio was identical, with a greater proportion of
males (Table 2).
Table 2. Comparison of included patients vs. all wheezing/asthmatic patients.
Variable Included Patients All Patients p-Value
n 129 304
Sex ratio (M:F) 2.3:1 2.3:1
Age at First Wheezing Episode (mo) 10.0 ± 0.6 12.3 ± 0.4 0.0004
Number of Wheezing Episodes * 1.8 ± 0.1 1.2 ± 0.04 <0.0001
Cumulative duration (days) of
Hospitalization * 8.7 ± 0.5 4.6 ± 0.2 <0.0001
* Observed during the first 2 years of life.
Regarding exposure to passive smoking and mothers’ associated behavior, 49/129
(38%) of women had been exposed to passive smoking during their pregnancy (partner
smoking), 31/47 (66%) in the exposed group and 18/82 (22%) in the unexposed group.
Fifty six infants (43%) were exposed to post-natal passive smoking, 41/47 (98%) in the
exposed group, 10/82 (12%) in the unexposed group.
In the exposed group, 87% of infants were exposed until the third trimester pregnancy
and 10% during the first trimester, only. Six percent of the mothers had quit smoking
in anticipation of their pregnancy and 83% had reduced their consumption. Eight and a
half percent of women reported measuring exhaled carbon monoxide during pregnancy
follow-up, 66% would have liked more help regarding smoking cessation and 60% had
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received information about the risk of asthma for their child if they were smoking during
their pregnancy. The mean reported daily cigarette consumption throughout pregnancy
was 7.6 ± 4.7 cigarettes. Forty-nine percent (23/47) of mothers reported smoking fewer
than five cigarettes per day, 13/47 (27.6%) between six and 10 cigarettes and 11/47 (23.4%)
between 11 and 20 cigarettes. In the group exposed to antenatal smoking (n = 47, 36.4%),
48.9% of mothers reported smoking fewer than five cigarettes per day, 27.6% between six
and 10 cigarettes and 23.4% between 11 and 20 cigarettes.
Regarding the primary outcome measure (Table 3), there was a significant difference
in the hospitalization duration/age ratio between the exposed and unexposed groups
(0.9 days/month in the exposed group, 0.58 days/month in the unexposed group, p = 0.008).
Of note, the median length of hospitalization/age in the overall cohort was 0.6 days/month
ranging from 0.1 to 6.5 days/month. Median hospitalization duration/age based on PTSE
increased with exposure. There was a difference of 0.2 days/month between the unexposed
group and the group with low cigarette consumption ((1–5) cigarettes per day), a difference
of 0.35 days/month between the low and medium exposure groups ((6–10) cigarettes),
and a difference of 0.32 days/month between the medium and high level exposed groups
((11–20) cigarettes). There was a 54% increase in duration of hospitalization in the exposed
versus the unexposed group.
Table 3. Duration of the hospitalization/age (days/months) depending on prenatal exposure to
tobacco.
Exposure Median Q1–Q3 Min–Max
Total cohort 0.6 0.35–1.2 [0.1–6.5]
Unexposed 0.58 0.3–0.86 [0.13–5.67]
Exposed (all groups) 0.9 0.44–1.5 [0.1–6.5]
Exposed [1–5] cig. 0.78 0.33–1.29 [0.1–2.5]
Exposed [6–10] cig. 1.13 0.5–1.4 [0.4–3.6]
Exposed [11–20] cig. 1.45 0.56–2.6 [0.21–6.5]
Cig: cigarettes per day; PTSE: Prenatal Tobacco Smoke Exposure; Q1–Q3: First and third quartiles.
In the univariate analysis, as depicted in Figure 1, there was a linear relationship
between prenatal tobacco smoke exposure and duration of hospitalization/age (r = 0.238,
slope = 0.055, (95% CI: 0.02–0.09), p = 0.006). Smoking one cigarette per day during
pregnancy was statistically associated with an increase in hospital stay of 0.055 days/month
over the first 2 years of life.
Upon multivariable analysis, after adjusting for confounding factors related to other
risk factors for wheezing (such as the passive exposition for the pregnant women or in the
post-natal period, gender, intrauterine growth restriction, familial atopy), smoking one
cigarette per day during pregnancy was statistically associated with an increase in hospital
stay of 0.06 days/month of life over the first 2 years of life (p = 0.03), as depicted in Table 4.
The standardized β of this association was 0.27 after standardization of the coefficients, i.e.,
an increase by one standard deviation of the independent variable (number of cigarettes
smoked per day during pregnancy) induced an increase of 0.27 SD of the hospital stay (in
days/month).
Regarding the secondary endpoints (Table 5), the descriptive analysis of the relation
between the quantification of the exposure and the secondary endpoints revealed a dose-
effect trend. Upon multivariable analysis, there was no significant association between
PTSE and all the secondary endpoints: the severity of the dyspnea during hospitalization:
OR = 1.033, p = 0.67, CI95% (0.89–1.19); how mothers experience their child’s hospitalization:
β = −0.04 and p = 0.32, CI95% (−0.12–0.02); rate of parental work absenteeism: β = 1.52
and p = 0.43, CI95% (1.25–1.74); age of first wheezing episode: β = −0.12 and p = 0.26,
CI95% (−0.33–0.09); number of emergency department visits: β = 0.079 and p = 0.25, CI95%
(0.01–0.17).
Healthcare 2021, 9, 1089 5 of 11




Figure 1. Linear correlation between duration of hospitalization/age and reported number of cigarettes smoked during preg-
nancy. 
Upon multivariable analysis, after adjusting for confounding factors related to other 
risk factors for wheezing (such as the passive exposition for the pregnant women or in the 
post-natal period, gender, intrauterine growth restriction, familial atopy), smoking one cig-
arette per day during pregnancy was statistically associated with an increase in hospital stay 
of 0.06 days/month of life over the first 2 years of life (p = 0.03), as depicted in Table 4. The 
standardized β of this association was 0.27 after standardization of the coefficients, i.e., an in-
crease by one standard deviation of the independent variable (number of cigarettes smoked 
per day during pregnancy) induced an increase of 0.27 SD of the hospital stay (in days/month). 
Table 4. Duration of hospitalization/age in multivariable analysis. 
Variable β 95% CI Standardized β 95%CI Standardized β p-Value 
PTSE 0.06 0.01–0.11 0.27 0.03–0.51 0.03 
Passive smoking pregnant women 0.29 −0.15–0.73 0.13 −0.07–0.33 0.20 
Post-natal passive smoking −0.34 −0.86–0.17 −0.16 −0.40–0.08 0.18 
Gender (male) 0.05 −0.36–0.46 0.02 −0.15–0.20 0.81 
Intra-Uterine Growth Restriction 0.69 0.04–1.35 0.03 0.01–0.35 0.04 
Familial Atopy −0.001 −0.37–0.36 −0.004 −0.17–0.17 0.96 
Personal Atopy 0.11 −0.25–0.49 0.06 −0.11–0.23 0.53 
β: regression coefficient; PTSE: Prenatal Tobacco Smoke Exposure. 
Regarding the secondary endpoints (Table 5), the descriptive analysis of the relation 
between the quantification of the exposure and the secondary endpoints revealed a dose-
effect trend. Upon multivariable analysis, there was no significant association between PTSE 
and all the secondary endpoints: the severity of the dyspnea during hospitalization: OR = 
1.033, p = 0.67, CI95% (0.89–1.19); how mothers experience their child’s hospitalization: β = 
−0.04 and p = 0.32, CI95% (−0.12–0.02); rate of parental work absenteeism: β = 1.52 and p = 0.43, 
Number of cigarettes
































Figure 1. Linear correlation between duration of hospitalization/age and reported number of
cigarettes smoked during pregnancy.
Table 4. Duration of hospitalization/age in multivariable analysis.
Variable β 95% CI Standardized β 95%CIStandardized β p-Value
PTSE 0.06 0.01–0.11 0.27 0.03–0.51 0.03
Passive smoking
pregnant women 0.29 −0.15–0.73 0.13 −0.07–0.33 0.20
Post-natal passive
smoking −0.34 −0.86–0.17 −0.16 −0.40–0.08 0.18
Gender (male) 0.05 −0.36–0.46 0.02 −0.15–0.20 0.81
Intra-Uterine
Growth Restriction 0.69 0.04–1.35 0.03 0.01–0.35 0.04
Familial Atopy −0.001 −0.37–0.36 −0.004 −0.17–0.17 0.96
Personal Atopy 0.11 −0.25–0.49 0.06 −0.11–0.23 0.53
β: regression coefficient; PTSE: Prenatal Tobacco Smoke Exposure.














Unexposed 53/82 (64.6) 2.45 ± 1.24 (1.82–3.07) 49/82 (59.8) 5 (2–8) 2 (1–4)
Exposed (all groups) 37/47 (78.7) 1.61 ± 1.40 (0.91–2.32) 26/47 (55.3) 4 (2–6) 2 (1–4)
[1–5] cig./day 17/23 (73.9) 1.82 ± 1.55 (1.04–2.06) 13/23 (56.5) 4 (3–6) 2 (1–2)
[6–10] cig./day 11/13 (84.6) 1.23 ± 1.23 (0.61–1.84) 8/13 (61.5) 2 (1–5) 3 (3–4)
[11–20] cig./day 9/11 (81.8) 1.63 ± 1.28 (0.99–2.27) 6/11 (54.3) 3 (2–5) 3 (1–5)
n/N (%); Mean ± SD (95% CI); median (Q1–Q3); Cig.: cigarettes; * Severe dyspnea was defined as oxygen requirement, and/or
complications such as pneumonia or atelectasis; ** Mothers graded from 0 (very bad experience) to 5 (good) their experience of their child’s
hospitalizations.
4. Discussion
In the present study, we found a significant dose-effect relationship between prenatal
tobacco smoke exposure and the duration of hospitalization for wheezing in non-premature
infants below 24 months of age. For each cigarette smoked per day during pregnancy, there
was a risk of increasing the duration of hospitalization by 0.055 days per month over the
infant’s first two years of life. For a 12-month-old infant exposed to 10 cigarettes per day
antenatally, there was a risk of increasing his stay by 6.6 days and 4.8 days, according to the
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univariate analysis and the multivariable analysis, respectively. There was a 54% increase
in the duration of hospitalization in the exposed vs. the unexposed group. There was
no dose threshold above which the duration of hospitalization would increase further, or
below which there would be no risk. Regarding the secondary endpoints, there were non-
significant trends towards a similar dose-effect relationship. The severity score tended to
increase (20% difference between unexposed group and group exposed to heavy smoking),
the mothers’ grading of how they experienced the admission tended to decrease (remaining
below 2.5 indicating that hospitalization is difficult for all patients) and the age of the first
wheezing episode tended to decrease with exposure.
4.1. Demographics and Risk Factors for Hospital Admission
The patients included in this hospital-based study represent a sample population at
high-risk for wheezing. Preschoool wheezing is one of the main causes of hospitalization in
children aged <5 years [10], who suffer disproportionally more often from severe “asthma”
exacerbations requiring emergency visits and hospital admissions compared to school-aged
children [11]. Population-based data in French schoolchildren in the last year of nursery
school (aged 5 years) indicated a lifetime prevalence of “asthma” of 11.0% [12]. In a birth
cohort study conducted in Manitoba, Canada, the cumulative risk of hospitalization during
the age interval 0–4 years for males and females were 2.1% vs. 1.1%, respectively [13].
Moreover, once admitted to hospital, the rate of emergency presentations (emergency
department and readmission) within 12 months after discharge is high (20.5%) [11], and
increases further with the number of prior hospitalizations and physician visits [13].
Preschool “asthma” and wheezing episodes are of multifactorial origin. Host (genetics,
atopy) and environmental factors (viral and microbial exposure, exposure to passive
smoking and indoor and outdoor air pollution, diet, exercise, vitamin intake, etc. [10]
and low socioeconomic status [12] all play a role in asthma onset, prevalence and control.
Moreover, gender may have a significant impact on asthma risk. In boys, the development
of peripheral and bronchial airway dimensions relative to the growth of lung volume is
delayed (mainly after the age of 4–5 years) vs. girls [14]. During the first year of life, males
had approximately three times the probability of hospitalization due to asthma as females,
and the cumulative risk of hospitalization during the preschool age for males was nearly
twice that of females [13].
In our study, there were notable differences between the two groups (PTSE vs. no
PTSE). For example, in the exposed group, male predominance is very marked. This
confirms previous studies reporting higher hospitalization rates for asthma amongst boys
than girls [6], and male sex as a risk factor for the recurrence of pre-school wheezing [15].
Prenatal tobacco smoke exposure is known to reduce birth weight [16]. Mean birth weight
was lower in the exposed group, but the mean weights of the two groups were within
the normal range, without any difference in the rate of intrauterine growth restriction.
Regarding atopy and phenotypes predicting evolution to persistent asthma, the two groups
are comparable, with atopy occurring in half of all hospitalized patients regardless of
exposure. The mean age of hospitalization was between 8 and 11 months depending on the
group. In the exposed group, the mean age of hospitalization and the age at first hospital
admission were 2 months less in the exposed group, so a respiratory event is likely to have
occurred earlier.
The declared rate of prenatal tobacco smoke exposure, greater than 33%, was higher
than the 17% reported in France [17]. This may be related to a selection bias. Rates of other
types of passive smoking were also different [18]. One-third of mothers reported smoking
at least 10 cigarettes a day according to the literature [17], contrasting with one-quarter in
the present study. Half of them reported a low level of consumption and most of them had
smoked throughout their entire pregnancy. Most children who were exposed to prenatal
tobacco smoke were also exposed subsequently to post-natal smoke. Of note, in a previous
report, the odds ratio of maternal smoking for transient early wheezing (vs no wheezing)
was 2.2 (95% CI 1.3–3.7) [7].
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Taken together, the requirement for hospitalisation in the present study cohort may
be due to the addition of many risk factors (PTSE+male sex+lower birth weight+ lower
socioeconomic status). PTSE per se as a sole risk for acute wheezing may represent a health
issue of lesser degree in the general population.
4.2. Clinical Impact and Economic/Social Consequences
The dose-effect impact of TPSE on hospitalization for wheezing which we have
demonstrated cannot be compared directly with the literature, since studies analyzing the
effect of prenatal tobacco smoke exposure until now have focused on the incidence and risk
factors of wheezy dyspnea and asthma [19–22]. Presumably, more tobacco smoke exposes
the foetus to greater structural changes and their clinical consequences. Liu et al. observed
that low-intensity cigarette consumption during either the first or second trimester of
pregnancy, even as low as 1–2 cig/day, was associated with an increased risk of preterm
birth [23]. In a prospective analysis of a large birth cohort, Lanari et al. have reported that,
when considering PTSE, having a mother smoking more than 15 cigarettes every day or
a mother exposed to second hand smoke were associated with a significant risk increase
of hospitalization for bronchiolitis of 3.5 (CI 1.5–8.1) and of 1.7 (1.1–2.6), respectively [24].
Carlsen et al. studied tidal breathing parameters at 3 days of life and demonstrated a
significant reduction in change in tidal breathing expiratory flow to total expiratory time
ratio (t PEF/t E) in infants exposed in utero to maternal smoking [25]. One daily cigarette
corresponded to a change in t PEF/t E of −0.0021 ((95% CI) −0.0040 to −0.0002) and a
change in Crs of −0.026 mL·cmH2O (95% CI −0.045 to −0.007 mL·cmH2O). The decrease
was 0.023 and 0.29, respectively, in infants of an average smoker [25]. The ratios declined
with increasing exposure [25]. All the above, together with our findings, suggest that there
is a no-threshold dose-effect relationship between prenatal tobacco smoke exposure and
the duration of hospitalization for wheezing in infants during the first 1000 days.
Apart from the economic impact of hospital admissions due to PTSE (discussed
below), the real life relevance and treatment burden of acute wheezing episodes relate
to more frequent visits to the hospital, longer hospital stays, and the hidden burden of
long-term maintenance anti-asthma therapy. Parents of admitted children have generally
been counseled regarding the risk of long-term COPD and lung cancer due to cigarette
smoking, but most report total ignorance of the disruption to family life (including the care
of other siblings) and the weariness during the first 1000 days of their child’s life, as a direct
consequence of PTSE. The direct impact of PTSE includes: (1) parents’ loss of time and
energy as a result of repeated long waiting times in the Accident and Emergency depart-
ments; (2) hospital admissions usually last for 2 to 4 days, and longer stays will mean more
bronchodilator aerosols, oxygen therapy, oral steroids, aid for feeding difficulties, IV fluids,
nosocomial infections (occasional re-admission of viral gastro-enteritis), antibiotics and
investigations such as chest X-rays; (3) moreover, long-term maintenance inhaled therapies
at home may be required (inhaled steroids and/or anti-leukotriene receptor antagonists-,
since exposure to passive smoking decreases the efficacy of inhaled steroids [26]). In many
cases, wheezing is due to a combination of smaller airways inherent to PTSE and viral
episodes, which are not responsive to conventional anti-inflammatory drugs, but which
lead to over-prescription by physicians, who are unaware of specific wheezing phenotypes.
4.3. Economic/Social Consequences
Overall, asthma-related costs vary significantly across countries, depending on several
factors, in particular the type of health system available. The socio-economic cost of
childhood asthma includes direct, indirect, and intangible costs [10]. Direct costs generally
account for 50–80% of the total costs and include disease management (e.g., outpatient
visits, visits to emergency services, hospital admission, medications), investigations and
other costs (e.g., home care, transportation to medical visits and hospital) [10]. In our
institution, each additional hospitalization day will cost between 614 and 118,800 € per
child [27]. Indirect costs include school and/or work-related losses and early mortality [10].
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A child with an asthma exacerbation loses on average 3–5 days school days and at least
one of her/his caregivers loses the same working time. Intangible costs are unquantifiable
(impairment of quality of life, limitation of physical activities and schooling and study
performance), with consequent psychological effects such as depression and anxiety [10].
In essence, the overall social burden of asthma is considerable, not only for the child but
also for his/her parents and carers.
4.4. Pathophysiology
The pathophysiology of lung involvement due to antenatal smoking is now better
known. Nictotine appears to be the main culprit. In vitro, in embryonic murine lung
explants, nicotine stimulated lung branching and dysanaptic lung growth occur in a dose-
dependent fashion [28]. This depends on the presence of alpha7 nicotinic acetylcholine
receptors (nAChRs) [28] in pulmonary fibroblasts [29]. Nicotine interacts directly with
alpha 7 nAChR to increase collagen accumulation in cartilaginous membranes and terminal
airways as well as alveolar walls, therefore increasing airway wall thickness [29]. The
greater inner and outer airway wall and the smooth muscle area and decreased alveolar
attachment points (reduction of the surface complexity of the lung parenchyma; less
elastic recoil) results in increased airway responsiveness i.e., excessive airway narrowing in
response to irritants encountered during the postnatal period [30]. Other changes include
epithelial cells proliferation, disruption of its cilia, and presence of inclusion bodies [31],
upregulation of surfactant protein gene expression, induction of neuro-endocrine cell
hyperplasia in fetal lungs, lowered serum IgG and decreased activity and numbers of
natural killer cells [32]. On the maternal side, nutrition may be an important issue. Smokers
during pregnancy had lower intakes of most micronutrients, in particular with respect to
vitamin C and carotenoid, and this may impact lung development [33]. Antioxidant intake
was lowest in young women who smoked [33]. Noteworthy, since much of the effect of
prenatal smoking on offspring lung function is mediated by nicotine, it highly likely that
e-cigarette use during pregnancy will have the same harmful effects as do conventional
cigarettes [34].
4.5. Smoking Cessation
Prenatal smoking is arguably one of the most important modifiable risk behaviors
for long-term child health. The data regarding the desire to receive smoking cessation
support and information about the respiratory risks of PTSE underline the problem of
prevention and support for smoking cessation: how effective they are, how they are
implemented, and what do pregnant women gain from them. Furthermore, less than 10%
of pregnant smokers report that their expired carbon monoxide was measured during
their pregnancy and more than half expressed a desire for more appropriate smoking
cessation support. Since passive smoking is a public health problem, several measures
have been implemented in recent years to improve prevention. Other types of prevention
and smoking cessation assistance have also been envisaged. Meta-analyses have evaluated
the impact of specialized interventions within families regarding the effect of smoking
cessation and the gain in children’s health. For example, one of the 18 trials analyzed
showed a cessation rate of 23.1% in the intervention group versus 18.4% in the control
group, so they can be considered to be worthwhile [35].
A suitable moment for learning is any circumstance during which a positive change in
behavior can take place [36]. This might be a particular setting, offering an opportunity to
promote awareness of the problem [37]. The motivation to quit smoking is all the greater
if parents grasp the beneficial impact on their child’s health. Pregnancy is a key time for
weaning and early management. The period during which a child is hospitalized is also a
window of opportunity for identifying parents who smoke and offering them appropriate
weaning assistance [38]. In addition to obstetricians, pediatricians can play a central role in
this respect. They can greatly influence parents and put forward convincing arguments
about smoking cessation and the positive effect this can have on their children. Another
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issue to be considered is the time and effort that pediatricians must devote to learn how to
help parents to stop smoking. A randomized study evaluating the impact of a smoking
cessation education program for pediatric pulmonologists and nurses in a Philadelphia
children’s hospital reported significant results. The group that received specific training
had a better approach to parents who smoked, provided higher level counselling and more
practical help [39].
Efforts to promote prevention should be reinforced and probably include a minimum
level of training for health workers for the evaluation of smoking, giving appropriate
advice, and organizing dedicated meetings. Passive smoking has a significant cost in
terms of pediatric morbidity and mortality. For example, in United States, it has been
estimated that parental smoking is responsible for excess illness and death in children
each year due to low birth weight (46,000 cases), unexpected infant deaths (2000 cases),
RSV bronchiolitis (22,000 hospitalizations, 1100 deaths), and asthma (1.8 million outpatient
visits and 14 deaths) [40].
Smoking reduction is more likely to occur than complete cessation during pregnancy
and the message “less consumption entails less risk” seems too banal, given that even low
cigarette consumption has negative repercussions on fetal development. A recent French
study showed that even low exposure to prenatal tobacco smoke exposure was associated
with a significant reduction in birth weight [17]. PTSE is an early and modifiable risk factor:
it is the first on which all health professionals must mainly act.
4.6. Strengths
The strengths of the study were as follows. First, it is one of the few to attempt to
quantify PTSE in a cohort of hospitalized infants. Second, the duration of hospitalization
standardized to age improves the comparability of hospitalization times in infants hospital-
ized several months apart. Third, the long inclusion period (one and a half year) covered
several seasons, thereby reducing the bias of seasonal epidemics.
4.7. Limitations
First, this study was retrospective with a medium-sized cohort and limited power
(more unexposed and low exposure groups than a high exposure group). The questionnaire
participation rate was moderate (129/237 (54%)), and we did not perform any comparison
of the demographic and clinical characteristics of participants vs. non-responded subjects.
Second, a recall bias may have occurred [41,42]. Declarative reporting frequently results
in underreporting of consumption due to guilt and underestimation of risk. Studies have
shown that the reporting mode alone may underestimate the number of women smokers
by 20% and the number of cigarettes smoked by 50% [20]. In addition, a memory bias was
possible since we asked mothers about their cigarette consumption 1 to 2 years prior to the
study. Third, the main result of the univariate analysis does not take into account other
confounding factors that might increase the risk of preschool wheeze (place of residence,
presence of mold in the child’s bedroom, ethnicity, breastfeeding, season, number of
siblings, or community, fetal exposure to alcohol, drugs and environmental pollutants.
Fourth, it is difficult to unravel the influence of the different types of passive smoking,
which are often associated (98% of patients exposed to prenatal tobacco smoke exposure
were also exposed to post-natal passive smoking). The measured impact probably arose
from these two types of exposure. However, the multivariable analysis tended to offset
this limitation.
5. Conclusions
We found a no-threshold dose-effect relationship between prenatal tobacco smoke
exposure and the duration of hospitalization for wheezing in non-premature infants less
than 2 years of age, indicating that there is no safe level or safe trimester regarding PTSE.
Although future studies are required to confirm these findings, the medical community
should act with more urgency by seeking out ways to provide more intensive and effective
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smoking cessation assistance to reduce the number of children exposed to passive smoking.
Offering stronger smoking cessation education programs during pregnancy is a priority.
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